LivaNova plc Stock
LivaNova plc Stock
We can see a decrease in the price for LivaNova plc. Compared to yesterday it has lost -€1.000 (-1.790%).
With 12 Buy predictions and not the single Sell prediction the community is currently very high on LivaNova plc.
As a result the target price of 59 € shows a slightly positive potential of 7.27% compared to the current price of 55.0 € for LivaNova plc.
Pros and Cons of LivaNova plc in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of LivaNova plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| LivaNova plc | -1.790% | 0.917% | -7.563% | 53.631% | 4.762% | 38.191% | -11.290% |
| Bio-Rad Labs Inc. A | -0.660% | 2.341% | 5.300% | 8.094% | -6.786% | -44.455% | -50.535% |
| Neogen Corp. | 1.920% | 3.871% | -16.146% | 0.000% | 30.894% | - | - |
| CONMED Corp. | - | -4.403% | -21.649% | -45.225% | -13.143% | -67.660% | -72.613% |
Comments
LivaNova (LIVN) had its price target raised by Needham & Company LLC from $64.00 to $81.00. They now have a "buy" rating on the stock.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova (NASDAQ:LIVN) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Show more
Ratings data for LIVN provided by MarketBeat
LivaNova (NASDAQ:LIVN) had its price target raised by analysts at Stifel Nicolaus from $65.00 to $70.00. They now have a "buy" rating on the stock.
Show more
Ratings data for LIVN provided by MarketBeat